FdaApplication
ANDA 211427
Identifiers
- fda_app_no: ANDA211427
Properties
| Property | Value |
|---|---|
| applicant_name | MACLEODS PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2025-01-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL |
2 products